GDTC logo

GDTC EBITDA

Annual EBITDA

-$2.75 M
-$859.60 K-45.36%

December 31, 2023


Summary


Performance

GDTC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGDTCprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

GDTC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-45.4%--
3 y3 years-147.0%--
5 y5 years-147.0%--

GDTC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-130.7%at low
5 y5-year-147.0%at low
alltimeall time-147.0%at low

CytoMed Therapeutics Limited EBITDA History

DateAnnualQuarterlyTTM
Dec 2023
-$2.75 M(+45.4%)
-
-
Dec 2022
-$1.90 M(+58.7%)
-
-
DateAnnualQuarterlyTTM
Dec 2021
-$1.19 M(+7.1%)
-
-
Dec 2020
-$1.12 M
-
-

FAQ

  • What is CytoMed Therapeutics Limited annual EBITDA?
  • What is the all time high annual EBITDA for CytoMed Therapeutics Limited?
  • What is CytoMed Therapeutics Limited annual EBITDA year-on-year change?

What is CytoMed Therapeutics Limited annual EBITDA?

The current annual EBITDA of GDTC is -$2.75 M

What is the all time high annual EBITDA for CytoMed Therapeutics Limited?

CytoMed Therapeutics Limited all-time high annual EBITDA is -$1.12 M

What is CytoMed Therapeutics Limited annual EBITDA year-on-year change?

Over the past year, GDTC annual EBITDA has changed by -$859.60 K (-45.36%)